Analytical researchers have developed and fully validated a high-performance liquid chromatography–tandem mass spectrometry method to simultaneously quantify nine cannabinoids and metabolites in whole blood collected via volumetric dried microsampling. The analytical protocol was designed to address the expanding therapeutic application of cannabinoid formulations and the increasing diversity of cannabis products, which require monitoring a broad panel of pharmacologically active compounds from low-volume biological samples.
The target panel includes nine specific analytes: cannabidiol, 7-hydroxy-CBD, 7-carboxy-CBD, 6α-hydroxy-CBD, cannabinol, cannabigerol, Δ9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC. Chromatographic separation of the multi-cannabinoid panel was achieved on a C8 column coupled with electrospray ionisation operated in polarity switching mode.
Whole blood specimens were gathered using the hemaPEN device, an advanced volumetric dried blood microsampling system. The sampling technology incorporates a four-replicate architecture that collects four volumetrically identical dried blood spots by capillary action from a single fingerstick procedure, providing reproducible volumetric sampling for subsequent laboratory extraction.
To accommodate the wide dynamic range of cannabinoid concentrations in blood, the researchers established a dual-protocol extraction workflow. Cannabinoids expected at higher concentrations—specifically 11-nor-9-carboxy-THC, cannabidiol, 7-hydroxy-CBD, and 7-carboxy-CBD—were quantified from a single 2.74-microlitre paper disc, yielding lower limits of quantification between 2.0 and 5.0 nanograms per millilitre. Conversely, analytes requiring higher analytical sensitivity—Δ9-tetrahydrocannabinol, 11-hydroxy-THC, 6α-hydroxy-CBD, cannabinol, and cannabigerol—were extracted by pooling all four discs for a total volume of 10.96 microlitres, achieving lower limits of quantification of 0.5 nanograms per millilitre.
Validation testing confirmed the method’s performance across selectivity, linearity, precision, accuracy, extraction yield, matrix effect, hematocrit independence, and stability. Across six donor matrices, analyte extraction yields ranged from 67.8 percent to 81.7 percent, while internal standard-normalised matrix effects ranged between 89.6 percent and 98.6 percent. Analyte stability on the dried microsampling matrix was demonstrated at room temperature for at least 90 days for all nine monitored cannabinoids.
The method was successfully evaluated on authentic blood specimens, confirming quantitative capability across the complete target panel. The authors reported that the procedure provides a logistically practical tool for forensic and toxicological surveillance, therapeutic drug monitoring in patients undergoing cannabinoid therapy, and pharmacokinetic profiling in clinical and preclinical research settings.
Subject of Research: Volumetric dried blood microsampling for multi-cannabinoid quantification
Article Title: Non-psychotropic phytocannabinoids, Δ9-THC and their metabolites by means of volumetric dried blood microsampling
Article References: Noreen, S., Mandrioli, R., Di Lecce, R., Iattoni, C. P., Castrovilli, M. C., Protti, M., & Mercolini, L. (2026). Non-psychotropic phytocannabinoids, Δ9-THC and their metabolites by means of volumetric dried blood microsampling. Journal of Cannabis Research. https://doi.org/10.1186/s42238-026-00503-y
Image Credits: AI Generated
DOI: 10.1186/s42238-026-00503-y
Keywords: Volumetric dried blood microsampling, HPLC-MS/MS, hemaPEN, Cannabinoids, Cannabidiol, Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-THC, 11-hydroxy-THC, Cannabinol, Cannabigerol, Therapeutic drug monitoring, Forensic toxicology, Pharmacokinetics, Dried blood spots, Capillary microsampling, Electrospray ionisation
Cite Scienmag News
Louis Brooks. (November 18, 2026). Dried Blood Microsampling Method Quantifies Nine Cannabinoids and Their Metabolites. Scienmag. https://scienmag.com/dried-blood-microsampling-method-quantifies-nine-cannabinoids-and-their-metabolites/
Louis Brooks. "Dried Blood Microsampling Method Quantifies Nine Cannabinoids and Their Metabolites." Scienmag, 18 November 2026, https://scienmag.com/dried-blood-microsampling-method-quantifies-nine-cannabinoids-and-their-metabolites/. Accessed 19 November 2026.
Louis Brooks. "Dried Blood Microsampling Method Quantifies Nine Cannabinoids and Their Metabolites." Scienmag. November 18, 2026. https://scienmag.com/dried-blood-microsampling-method-quantifies-nine-cannabinoids-and-their-metabolites/








